Internal balance sheet | 31.12.2022 | 31.12.2021 |
ASSETS | ||
NON-CURRENT ASSETS | ||
Intangible assets Other long term expenses Intangible assets in total |
5 345 224,33 72 021,31 5 417 245,64 |
|
Tangible assets Other long term expenses Tangible assets in total |
1 949 978,58 4 035 406,31 385 457,61 6 370 842,50 |
57 802,97 2 664 064,97 2 921 536,23 5 643 404,17 |
Investments Other shares and similar rights of ownership |
1 558,60 |
1 558,60 |
CURRENT ASSETS |
||
Inventories Materials and accessories Inventories in total |
4 375 497,00 458 838,18 4 834 335,18 |
3 883 504,00 362 386,18 4 245 890,18 |
Long Term Receivables Security deposits |
832 017,23 |
832 017,23 |
Short term receivables Accounts receivable Short term receivables in total |
3 902 826,22 |
683,30 1 182 640,59 |
Financial instruments Other shares and stock |
50 685 049,16 |
55 386 309,31 |
Cash in hand and in bank |
18 532 986,99 |
30 292 809,11 |
TOTAL ASSETS | 92 292 661,41 | 104 473 822,32 |
EQUITY AND LIABILITIES | ||
EQUITY | ||
Blood Service Research Fund Profit for previous financial years Profit for the financial year TOTAL EQUITY |
22 472 097,43 71 918 829,99 -12 968 361,24 81 422 566,18 |
23 051 309,70 65 435 722,47 5 903 895,25 94 390 927,42 |
EXTERNAL LIABILITIES |
||
Current Accounts payable Current liabilities in total
|
|
|
TOTAL EQUITY AND LIABILITIES |
92 292 661,41 |
104 473 822,32 |